key: cord-0280708-1ih02d05
authors: Moukheiber, Lama; Mangione, William; Moukheiber, Mira; Maleki, Saeed; Falls, Zackary; Gao, Mingchen; Samudrala, Ram
title: Identifying protein features and pathways responsible for toxicity using machine learning and Tox21: Implications for predictive toxicology
date: 2022-04-29
journal: bioRxiv
DOI: 10.1101/2021.12.13.472455
sha: 081eb11d118cda658bcbcfe2b25322c8ed06b8e2
doc_id: 280708
cord_uid: 1ih02d05

Humans are exposed to numerous compounds daily, some of which have adverse effects on health. Computational approaches for modeling toxicological data in conjunction with machine learning algorithms have gained popularity over the last few years. Machine learning approaches have been used to predict toxicity-related biological activities using chemical structure descriptors. However, toxicity-related proteomic features have not been fully investigated. In this study, we construct a computational pipeline using machine learning models for predicting the most important protein features responsible for the toxicity of compounds taken from the Tox21 dataset that is implemented within the multiscale Computational Analysis of Novel Drug Opportunities (CANDO) therapeutic discovery platform. Tox21 is a highly imbalanced dataset consisting of twelve in vitro assays, seven from the nuclear receptor (NR) signaling pathway and five from the stress response (SR) pathway, for more than 10,000 compounds. For the machine learning model, we employed a random forest with the combination of Synthetic Minority Oversampling Technique (SMOTE) and Edited Nearest Neighbor (ENN) method (SMOTE+ENN), which is a resampling method to balance the activity class distribution. Within the NR and SR pathways, the activity of the aryl hydrocarbon receptor (NR-AhR), and mitochondrial membrane potential (SR-MMP) were two of the top-performing twelve toxicity endpoints with AUCROCs of 0.90 and 0.92, respectively. The top extracted features for evaluating compound toxicity were analyzed for enrichment to highlight the implicated biological pathways and proteins. We validated our enrichment results for the activity of the AhR using a thorough literature search. Our case study showed that the selected enriched pathways and proteins from our computational pipeline are not only correlated with AhR toxicity but also form a cascading upstream/downstream arrangement. Our work elucidate significant relationships between protein and compound interactions computed using CANDO and the associated biological pathways to which the proteins belong for twelve toxicity endpoints. This novel study uses machine learning not only to predict and understand toxicity but also elucidates therapeutic mechanisms at a proteomic level for a variety of toxicity endpoints.

Exposure to persistent natural and synthetic environmental pollutants continues 42 to be a significant health concern [1]. With technological advances in computational 43 toxicology, systems biology, and bioinformatics, researchers and regulators have access 44 to tools that allow for rapid assessment of toxic compounds, reducing the use of low-45 throughput, expensive, and time-consuming in vivo animal testing [2, 3] . High-throughput 46 screening (HTS) [4, 5] has been utilized in conjunction with computational models to profile 47 compounds for potential adverse effects and assess how compounds interact with biological 48 systems. Furthermore, in the past few years, quantitative high-throughput screening (qHTS) 49 has emerged as a powerful tool to allow the study of toxicological pathways linked with 50 toxicity endpoints [6] . 51 The Toxicology in the 21st Century (Tox21) program has been established as a col-52 laborative effort among federal entities, including the National Center for Advancing 53 Translational Sciences (NCATS), the National Institute of Environmental Health Sciences 54 (NIEHS), the Environmental Protection Agency (EPA), and the Food and Drug Administra-55 tion (FDA), to advance toxicity assessment. This program has applied qHTS to profile a 56 library of around 10,000 compounds, including but not limited to environmental hazards, 57 industrial chemicals, drugs, and food additives [7] [8] [9] [10] . The Tox21 compound library was 58 run against a panel of seven nuclear receptors (NR) and five stress response (SR) pathway 59 assays, generating the most significant high-quality in vitro toxicity data to date [11] . Data 60 generated from Tox21 has been used to identify compounds that interact with specific 61 toxic pathways, including some not previously known [12] [13] [14] [15] . This data has also been 62 used, together with chemical structure information, to train predictive machine learning 63 models to compute whether a chemical will elicit a particular toxicological outcome based 64 on in vitro findings [16] [17] [18] [19] [20] [21] . Deep learning has achieved the best prediction performance in 65 toxicity prediction on the Tox21 data [22] . However, one major limitation of deep neural 66 networks is that they tend to mask the effective features for toxicity prediction. 67 We propose a novel approach to building a pipeline that predicts the essential proteins 68 implicated in in vivo toxicity, which are then fed into an enrichment analysis to assess 69 the mechanistic pathways contributing to each toxicity endpoint and provide a high-level 70 biological interpretation. To extract important protein feature descriptors which contribute 71 most to the target prediction, many feature selection techniques originating from machine 72 learning have been proposed [23] [24] [25] [26] . Random forest [27] , which is an embedded feature 73 selection technique, has emerged as an efficient and robust algorithm that can address 74 feature selection, even with a higher number of variables [28] [29] [30] . The random forest 75 approach constructs many decision trees during training and averages the predicted values 76 to obtain the final outputs. Due to the random exploration of features at each node in the 77 tree construction, random forest lends itself to feature selection. Determining and assessing 78 the most relevant feature descriptors between compounds and toxicity endpoints on a 79 mechanistic and proteomic scale will enable us to comprehensively evaluate compound 80 toxicity. 81 Previous studies using machine learning models on Tox21 data have shown that the 82 data is highly imbalanced, with a greater proportion of inactive or non-toxic compounds 83 for each toxicity assay. instances than active ones [31] [32] [33] . Highly imbalanced data can be a 84 problem when training machine learning classification models, as the model becomes biased 85 toward the inactive class, resulting in a higher misclassification rate for the active class. Most 86 of the previous classification algorithms using Tox21 data have not handled the imbalanced 87 problem for toxicity prediction explicitly [31, 32, 34, 35] . We propose an improved random 88 forest method for feature selection to find the relevant features for toxicity prediction, 89 i.e., random forest with the combination of Synthetic Minority Oversampling Technique 90 (SMOTE) and Edited Nearest Neighbor (ENN) method, aka SMOTE+ENN, a resampling 91 method to handle the imbalanced problem. 92 The Tox21 dataset has been well-studied using chemical descriptors as features to 93 understand toxicity [16, 33] . In contrast, this study utilizes the Computational Analysis of 94 Novel Drug Opportunities (CANDO) platform to obtain the protein feature descriptors to 95 understand toxicity at the protein pathway level. CANDO is a multiscale shotgun drug 96 discovery, repurposing, and design platform which employs multitargeting to generate 97 proteomic scale interaction signatures for any small molecule, including approved drugs, 98 against large libraries of protein structures from various organisms [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . The proteomic 99 interaction signatures are analyzed to computationally assess compound similarity, with 100 the premise that drugs with similar signatures may treat the same diseases. Version 3 of the 101 platform now features several protein-related and drug-related biological entities, such as 102 protein pathways, protein-protein interactions, protein-disease associations, and adverse 103 drug reactions, further enhancing the ability to compare small molecule compounds in the 104 context of biological systems. CANDO has been validated in multiple indications with 105 an overall success rate of 58/163, not including 51 drug candidates with activity against 106 SARS-CoV-2 (out of 275 ranked predictions) extracted from in vitro and electronic health 107 record-based studies published in the literature [46] . However, CANDO has yet to be 108 employed explicitly to predict compound toxicity, despite how conducive this multiscale 109 framework is for that task.

Our study aims to improve toxicity prediction by combining the capabilities of machine 111 learning, the CANDO platform, and enrichment analysis to identify the most effective 112 protein structures for predicting twelve toxicity endpoints from the Tox21 data and highlight 113 implicated biological pathways. We begin the study by pre-processing the data, generating 114 protein feature descriptors using CANDO, and performing dataset balancing. Following 115 this, we apply the random forest algorithm to select the top structural protein descriptors 116 and subject them to enrichment analysis to identify high-level biological entities that 117 explain the mechanisms through which the toxicity is induced. We provide a case study of 118 aryl hydrocarbon receptor (AhR) activation, comprehensively identifying the pathways 119 potentially responsible for its associated toxicity using only those identified via enrichment 120 analysis. Our approach of combining CANDO, machine learning, and feature selection 121 allows for a detailed understanding of compound behavior and a greater ability to predict 122 not only toxicity but also mechanistic etiology. 

In this section, we present (1) a summary of the curated and prepossessed Tox21 125 datasets; (2) performance metrics of our computational algorithm on the Tox21 data; (3) 126 a comparison between our study and other published Tox21 studies; (4) the enriched 127 pathways for the twelve Tox21 assays; and (5) a case study of NR-AhR toxicity with 128 published literature supporting our computational results and enrichment analysis. Figure 1 129 provides a high-level overview of our study design (section 4). Table 1 shows the preprocessed Tox21 compounds and their activities measured by 132 twelve qHTS in vitro assays. The number of active and inactive compounds for each of 133 the twelve qHTS assays was computed, along with the imbalance ratio, which is the ratio 134 of the majority class (inactive non-toxic compounds) to the minority class (active toxic 135 compounds). The imbalance ratio varied greatly between the twelve assays, with the 136 inactive compounds being the predominant majority (ratio 10:1 or higher) compared to 137 the actives. The higher the imbalance ratio value, the more imbalanced the activity class 138 distribution for the assay. In the training datasets, the imbalance ratio ranged from 5.52 139 for the SR mitochondrial membrane potential (SR-MMP) assay up to 37.62 for the NR 140 peroxisome proliferator-activated receptor γ (NR-PPAR-γ) assay. The test datasets had 141 imbalanced ratios equivalent to or larger than those of their corresponding training datasets, 142 ranging from 5.06 for the SR antioxidant response element (SR-ARE) assay up to 69.75 for 143 the NR androgen receptor ligand-binding domain (NR-AR-LBD) assay. Our study used the random forest classifier to avoid overfitting and enhance perfor-146 mance. Further, it was a commonly used model by participating teams in the Tox21 Data 147 Challenge. Two of the winning teams used a random forest model to achieve the best 148 performance in predicting compound toxicity against the NR-androgen receptor (NR-AR), 149 NR-aromatase, SR-p53 [20] , and NR estrogen receptor alpha ligand-binding domain (NR-150 ER-LBD) assay [19] . The area under the receiver operating characteristic curve (AUCROC) 151 Figure 1 . Overview of study workflow and pipeline for toxicity feature identification. As part of the data pre-processing step, the twelve Tox21 assay datasets containing the SMILES strings and activity class of the compounds were merged. The compounds were normalized and standardized using the MolVs library [50] , built on RDKit where compound duplicates with ambiguous activity labels (i.e., equally active and inactive labels for the same compound) were removed. Model features were generated using a protein-compound interaction matrix via the CANDO platform. The data containing the features and the class activity for each compound was generated for each of the twelve assays and split into training and test sets. The SMOTE+ENN algorithm was applied to oversample the minority class and obtain an augmented training subset used to train our random forest classifier. The parameters for the random forest classifier were selected using tenfold cross-validation to attain optimal model performance. The model was evaluated on the unseen test data with metrics such as F1-score, recall, precision, specificity, balanced accuracy, AUCROC, and AUPRC to evaluate its performance. The model was then used to obtain the top 100 important features (protein structures); proteins were associated with pathways annotated in Reactome. The overrepresented pathways in the top 100 proteins via enrichment analysis were identified. The enriched pathways for NR-AhR assay were analyzed as a case study which illustrates that our unique proteomic feature selection pipeline allows for a mechanistic understanding of compound toxicity. and the winning teams' balanced accuracy scores were provided as evaluation metrics 152 during the Tox21 Data Challenge. 153 Banerjee et al. [32] highlighted the importance of using sampling methods when 154 training a classifier on imbalanced chemical data, such as the Tox21 dataset. This is impor-155 tant because non-sampling methods on imbalanced data result in poor recall performance 156 due to the classifier favoring the majority inactive class [32] . Another study on a similar 157 methodology employed a random forest classifier with different resampling techniques 158 and showed that the random forest with SMOTE+ENN classifier performed the best on 159 the Tox21 data [31] . Therefore, in this study, we implemented the random forest and 160 SMOTE+ENN algorithms to train our model for feature selection and handle class imbal-161 ance. The SMOTE+ENN was applied to resample the training data, and the random forest 162 classifier was then fit to the training data. The trained model was used to make predictions 163 on the test data and was evaluated using classification performance metrics. This approach 164 was applied to each of the twelve assay datasets.

165 Table 2 reports the model evaluation metrics for the random forest classification model 166 for twelve qHTS assays. The reported values varied depending on metrics and assays. The 167 assays with a more favorable imbalance ratio perform much better. Overall, our modeling 168 approach achieved decent performance measured by AUCROC ≥ 0.7, except for NR-AR-169 LBD, which had very few active labels, as shown by its high imbalance ratio of 30.9 in the 170 training set. The AUCROC has the highest value of 0.92 for the SR-MMP, with the lowest 171 Table 1 . Details of compounds and their activity in the Tox21 dataset. Details are given for the pre-proccessed Tox21 Data Challenge training and test sets, including the assay identifier, target, and total number of compounds assayed, as well as the partitioning of the training and test sets. We compute the imbalanced ratio (IR) for each assay, which is the ratio of the inactive non-toxic compounds to the active toxic compounds. An imbalanced ratio value closer to one signifies a fairly balanced class activity, and a value much greater than one signifies a very imbalanced class activity. The imbalanced ratio values indicate that the Tox21 dataset is highly imbalanced and that model performance can be improved by taking this into account. imbalance ratio of 5.52 in the training set. This is not surprising as the greater the number of 172 active labels, the better the model's discriminatory power between the active and inactive 173 classes. The SR-MMP assay also had the highest F1-score of 0.49 and the highest recall and 174 high precision. The area under the precision-recall curve (AUPRC) score was also high for 175 SR-MMP, with a score of 0.60, signifying that the model could handle the positive samples 176 correctly.

177 Table 2 . Model evaluation metrics computed for the twelve Tox21 assay datasets. For each assay, the model's performance using F1, precision, recall, specificity, Mathews correlation coefficient (MCC), balanced accuracy (BA), AUROC, and AUPRC metrics is given. BA is the average of the recall and specificity and is a useful metric when evaluating imbalanced data. The overall performance of our pipeline is promising, particularly in terms of BA, depending on assays and metrics considered. We compared the performance of our approach with those employed in the Dmlab [20] , 178 and Microsomes [19] , which are the top two performing random forest models in the Tox21 179 Data Challenge. We also compared our results with the random forest with SMOTEENN 180 (SMN), which was the best random forest-based classifier employed by idakwo et al. 181 [31]. Since AUCROC and balanced accuracy are the only accuracy measures in the Tox21 182 Data Challenge, we only evaluated these two metrics in our results. Figure 2 depicts a 183 comparison of the model performance in terms of AUCROC and balanced accuracy of the 184 other studies and our study. On average, our model performed comparably to the Dmlab, 185 Microsomes, and SMN model approaches based on the AUCROC and balanced accuracy 186 metrics across most of the twelve assays. Yet our model allows for interpretability, as it 187 enables the extraction of important proteins implicated in each toxicity assay.

Despite the performance similarity with other studies, it is not a direct comparison 189 since our algorithm was used for feature selection, while the compared random forest-based 190 models are employed for prediction. Furthermore, such a comparison requires using the 191 same data pre-processing methodology and feature descriptors when training a model, 192 which was not done in this case.

193 Figure 2 . Comparison of model performance across the twelve Tox21 assays. The performance of the twelve Tox21 assays is evaluated using AUROC (top) and balanced accuracy (bottom). Although AUCROC is widely used as a binary classifier evaluation metric, it can be misleading for imbalanced classification with few examples of the minority class. We compared our results in blue to the three other studies which utilized a random forest based classifier. (The microsome study does not report both AUCROC and BA for the NR-AR, NR-AR-LBD, and SR-MMP assays and the BA for NR-PPARγ.) Our model performs comparably to previous methods yet allows for the extraction of important protein features implicated in each toxicity endpoint.

The top 100 most important protein features as determined by the random forest 195 algorithm for each Tox21 endpoint were subjected to enrichment analysis in the context of 196 protein pathways. The average number of enriched entities obtained for the twelve toxicity 197 endpoints was 36, with the minimum being 13 for NR-PPAR-γ and the maximum being 59 198 for SR-ATAD5. The exact proteins and pathways highlighted for the NR-AhR activation 199 assay are provided in Table 3 , including the total number of proteins in the pathway and 200 the calculated p-value. The full names and UniProt identifiers of those genes are available 201 in Table S1 . 202 2.4. Case study for NR-AhR 203 We selected the NR-AhR endpoint as a case study due to its model performance 204 relative to other NR assays. AhR is a helix-loop-helix ligand-activated transcription factor 205 that binds a wide range of ligands, including environmental pollutants, such as polycyclic 206 aromatic hydrocarbons (PAHs) and polyhalogenated aromatic hydrocarbons [51] . The 207 latter class of compounds includes halogenated dibenzo-p-dioxins, also known as dioxins. 208 One of the dioxin compounds is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is the 209 most commonly used environmental agent for studying AhR-mediated biochemical and 210 toxic responses because of its high affinity to AhR [52] . It also causes a wide range of toxic 211 effects, including immunosuppression and tumor promotion [53, 54] . Previous studies have 212 suggested that AhR signaling elicits numerous critical biological processes, including the 213 modification of the cell cycle, cell proliferation, immune responses, and tumorigenesis 214 [55-58]. Toxicity induced via AhR activation arises via genomic and non-genomic signaling 215 pathways ( Figure 3 ). The genomic signaling pathway involves the ligand-activated AhR 216 translocating in the nucleus and dimerizing with AhR nuclear translocator (ARTN). The 217 activated AhR/ARNT heterodimer complex interacts directly or indirectly with DNA by 218 binding to recognition sequences located in the promoter regions of dioxin-responsive 219 genes. This leads to adverse changes in cellular processes leading to the toxic response 220 [59,60]. The non-genomic signaling is due to the suppression or activation of certain 221 enzymes via the ligand-activated AhR [61] . 222 We assessed the interpretability of our pipeline by analyzing the NR-AR selected 223 proteins and enriched pathways to assess the toxic response. Based on our enrichment 224 analysis, the AhR signaling pathway is involved in 34 different toxic signaling pathways. 225 We analyzed a handful of pathways, including their corresponding proteins to illustrate 226 the validity of our toxicity analysis.

Several studies have shown that ligand-activated AhR is involved in toxicity and 228 cancer via DNA damage and cell cycle disruption. However, the molecular signaling mech-229 anism by which this occurs is unknown [ The schematic representation of the BRCA1 pathway is depicted in Figure 4 . A similar 237 study in the literature found that benzo[a]pyrene (BaP), a polycyclic AhR ligand [68], exerts 238 its carcinogenicity by inhibiting BRCA1. These studies indicate the participation of the AhR 239 pathway and its effects on DNA damage and cancer but do not mention the subsequent 240 downstream signaling pathway and protein regulation affected by the ligand-activated 241 AhR complex interaction. Furthermore, a study by Foo et al. highlighted that disruptions to 242 either the ataxia-telangiectasia mutated (ATM)-mediated phosphorylation and the cell cycle 243 G2-M checkpoint impact BRCA1-related cancers [69] . This supports our analysis as our 244 pipeline selected the ATM-mediated phosphorylation or the G2-M checkpoint pathways 245 Table 3 . Important mechanistic pathways and their proteins for the toxicity endpoint of NR-AhR. The name of the pathway, the number of proteins present in the pathway according to Reactome, the proteins in the pathway selected by the model as important for predicting AhR toxicity, and the p-value from the enrichment analysis are shown. The p-value is derived using the hypergeometric distribution based on how many total important proteins were selected by the model, how many total proteins are present in the pathway, and the total number of proteins in the human proteome. The value shown is the probability of selecting at least that number of proteins present in the pathway. These results indicate that our pipeline is capable of extracting higher level biological explanations associated with AhR toxicity that have been validated via the literature. as being involved in AhR toxicity, leading to the hypothesis that AhR ligands (BaP and 246 TCDD) interact with BRAC1 modulating these pathways.

Our pipeline selected BRCA1 as one of the important proteins in causing AhR toxicity, 248 corroborated by the research studies mentioned previously. This indicates that the toxic 249 AhR compounds in the Tox21 library cause carcinogenicity and DNA damage by binding 250 and modulating the activity of BRCA1. Further, we identified specific DNA damage 251 mechanisms (pathways and proteins) mediated by BRCA1, including the DNA double-252 strand break response, processing of DNA double-strand break ends, nonhomologous 253 Figure 3 . Overview of the NR-AhR signaling pathway. AhR is an inactive cytosolic transcription factor bound to several co-chaperones. When a ligand passively diffuses through the cell membrane and binds to AhR, the ligand-receptor complex translocates into the nucleus, and the chaperones dissociate. Once in the nucleus the AhR dimerizes with the AhR nuclear translocator (ARNT) forming an active heterodimer. The activated heterodimer complex interacts with DNA directly or indirectly by binding to recognition sequences located in the promoter regions of target genes, such as the xenobiotic response elements (XRE). BRCA1 modulates the expression of genes involved in xenobiotic stress responses [62], and was selected by our pipeline as an important protein feature in AhR toxicity. The binding of the heterodimer complex to the DNA activates the transcription of genes leading to proteins that affect inflammation, cell cycle, and immunological response. The toxicity of the ligand-activated AhR can also be mediated by the non-genomic action through enzymatic activation and the triggering of other pathways, such as the NF-κB pathway, which involves the TRAF6 protein, another important protein selected by our pipeline. The interconnection of different pathways as shown exemplifies how our pipeline can decipher different mechanisms for AhR toxicity induced by the toxic compounds. end-joining, ATM-mediated phosphorylation, and the G2-M checkpoint, along with other 254 proteins that play an essential role in DNA damage signaling and cell cycle control, such as 255 RNF8, UBE2N, RAP80 and NSD2, RPA1.

As previously mentioned, AhR is an important factor that regulates immune responses. 257 Several studies have implicated that the AhR signaling pathway interacts in autoimmune 258 and inflammatory diseases. BaP, an AhR ligand that is a prominent carcinogenic component 259 of cigarette smoke, smog, and some over-cooked foods [70] , has been shown to exert its 260 toxicity by inhibiting osteoclastogenesis through the activation of the nuclear factor-κB (NF-261 κB) pathway [71]. The NF-κB pathway is known to be involved in inflammatory arthritis, 262 and osteoclastogenesis [72, 73] . The TNF receptor-associated factor 6 (TRAF6), a protein 263 selected by our pipeline as involved in toxicity, is an essential factor for osteoclastogenesis. 264 It leads to the activation of the NF-κB pathway [74] . In addition to BaP, another AhR 265 ligand that contributes to inflammation is TCDD. TCDD has been shown to contribute to 266 rheumatoid arthritis, a chronic autoimmune disease that causes joint inflammation, bone 267 destruction, and increased pro-inflammatory cytokines, which is modulated by the NF-κB 268 pathway [75].

Double stranded breaks in DNA activate the ataxia-telangiectasia mutated (ATM) kinase and ataxia telangiectasia and Rad3-related protein (ATR) that subsequently phosphorylate checkpoint kinase 2 (CHK2) and checkpoint kinase 1 (CHK1). The ATR/ATM-mediated phosphorylation pathway phosphorylates the BRCA1 protein and activates proteins involved in DNA damage repair and apoptosis. The binding of toxic compounds or AhR ligands leads to the suppression of the BRCA1 promoter activity, ultimately leading to increased cellular toxicity via DNA repair dysfunction and cell cycle checkpoints disregulation. Our pipeline selected BRCA1 as important for predicting AhR toxicity, along with other proteins such as RNF8, UBE2N, RAP80, NSD2, and RPA1, implying that compounds known to induce this phenotype possibly via the modulation of proteins directly involved in DNA repair and cell cycle regulation.

Further, a study in the literature demonstrated that TCDD activates the p38-MAPK 270 pathway, implying a link between p38-MAPK signaling and AhR. It demonstrated that the 271 AhR and p38-mitogen-activated protein kinase (MAPK) induces the expression and activ-272 ity of c-Jun, a proto-oncogene [76], highlighting a novel mode of interaction between the 273 AhR and p38-MAPK pathway in carcinogenicity. Our algorithm selected the p38-MAPK-274 dependent pathway as important for AhR toxicity including JNK (c-Jun kinases) phospho-275 rylation and activation mediated by activated human TAK1 and activated TAK1 mediates 276 p38 MAPK activation. Our pipeline selected interconnected pathways, including MAPK 277 and NF-κB signaling, depicted in Figure 5 , highlighting that when compounds bind to the 278 proteins in these pathways and subsequently modulate their proper signaling, the outcome 279 is the observed toxic phenotypes.

The NF-κB signaling and MAPK pathway are illustrated in Figure 5 . One way the 281 NF-κB and mitogen-activated protein kinases (MAPK) pathways are activated is through 282 the Interleukin-1 receptor/toll-like receptor L-1R/TLR) and TLR7/8/9. Once IL-1R/TLR or 283 TLR7/8/9 is activated, it recruits the myeloid differentiation primary response 88 (MyD88). 284 MyD88 recruits interleukin-1 receptor-associated kinases (IRKA1/4).The IRKA1/4 complex 285 then recruits TRAF6 protein. Once TRAF6 is activated, it is recruited by UBE2N/UBC13, 286 which are ubiquitin-conjugating enzymes that catalyze the synthesis of a lysine-63 linked 287 polyubiquitin chain [77] . TRAF6 activates the TAK1 molecule, which activates several 288 downstream molecules. It activates the I-κB kinase (IKK) complex leading to the NF-κB 289 pathway activation. TAK1 can also activate MAPKs (P38 and c-Jun kinases (JNK)), which 290 in turn activates the AP-1 transcription factor. AP-1 enters the nucleus and causes the 291 transcription of pro-inflammatory cytokines. In addition to activating TAK1, TRAF6 can 292 also activate downstream interferon regulatory factor 7 (IRF7) via the TLR7/8/9-MyD88 293 pathway, leading to the production of Type 1 interferons.

Another way the NF-κB pathway is activated is through the TNFR1 receptor. Once 295 TNFR1 receptor is activated, the TRADD protein binds to a domain on the TNFR1 receptor. 296 Then the TNF receptor-associated factor 2 (TRAF2) and receptor-interacting protein 1 (RIP1) 297 kinase are recruited. The RIP1 protein ultimately activates the IKK complex. The IKK 298 complex consists of IKKα/IKKβ kinases and NF-κB essential modulator (NEMO). Then 299 IKK phosphorylates the Ikb protein, which masks the nuclear localization signal on NF-κB. 300 The phosphorylation of the Ikb protein causes its degradation by proteasomes, allowing 301 NF-κB to translocate into the nucleus. Once in the nucleus, NF-κB binds to genes such as 302 pro-inflammatory genes leading to cytokine production. 303 Figure 5 . Interconnectivity of the pathways leading to the activation of the NF-κB and MAPK signaling pathways that induce cellular inflammation. The Tumor Necrosis Factor Receptor 1 (TNFR1) plays an essential role in pro-inflammatory activities. Upon TNFR1's stimulation TNF receptor-associated factor 2 (TRAF2) is recruited along with receptor-interacting serine/threonineprotein kinase 1 (RIP1), which in turn activates transforming growth factor β activated kinase 1 (TAK1). TAK1 can also be activated through the Interleukin-1 receptor/toll-like receptor (IL-1R/TLR). Once IL-1R/TLR is activated it triggers the activation of the TNF receptor-associated factor 6 (TRAF6) downstream. TRAF6 then combines with ubiquitin-conjugating enzymes Ubc13/UBE2N and ultimately activates TAK1. TAK1 then activates nuclear factor-κB (NF-κB) signaling pathway, which recruits the NF-κB transcription factor, leading to the production of cytokines. TAK1 can also induce a cascade of mitogen-activated kinases (MAPKs), including the c-Jun kinases (JNKs) or the p38 MAPK. This activates the activator protein 1 (AP-1) transcription factor leading to the production of cytokines. In addition to activating TAK1, TRAF6 can also activate downstream interferon regulatory factor 7 (IRF7) via the TLR7/8/9-MyD88 pathway, leading to the production of type 1 interferon. TRAF6, TRAF2, and UBE2N were identified by our pipeline as important for predicting AhR toxicity, implying that these proteins may be modulated by compounds known to induce this toxic phenotype via the depicted pro-inflammatory pathways. TRAF6 was selected by our pipeline as an essential protein in predicting AhR toxi-304 city along with others such as UBE2N and TRAF2. A recent study highlighted that the 305 interaction between TRAF6 and UBE2N is crucial to the NF-κB inflammatory pathway 306 [78] . This signifies that one of the mechanisms by which AhR toxicity is induced is via 307 modulating proteins leading to autoimmune inflammation. Further, our pipeline identified 308 pathways connected with or upstream of the NF-κB pathway, including TRAF6 mediated 309 NF-κB activation, TRAF6 mediated IRF7 activation, IRAK1 recruitment of the IKK complex, 310 IRAK1 recruitment of the IKK complex upon TLR7/8 or 9 stimulation, TRAF6 mediated 311 IRF7 activation in TLR7/8 or 9 signaling, RIP1-mediated IKK complex recruitment, and 312 TAK1 activated NF-κB by phosphorylation and activation of IKKs complex. These multiple 313 interconnected pathways are depicted in Figure 5 . 314 Our AhR toxicity analysis shows that our algorithm selected proteins and their corre-315 sponding pathways that are corroborated by literature analysis. In addition, these selected 316 proteins overlap across multiple pathways, showing that toxicity is not due to single target 317 binding but rather a complex interconnected network involving many pathways. The over-318 lap in proteins and pathways indicates that our algorithm can potentially provide novel 319 insight into understanding toxicity from a proteomic and pathway perspective. However, 320 further prospective studies are warranted to elucidate the importance of these pathways in 321 AhR toxicity and the other toxicity endpoints. 323 While several studies in the literature have used chemical properties as feature de-324 scriptors to predict toxicity [16] [17] [18] [19] [20] [21] , this work is to our knowledge the first to use protein 325 descriptors for feature selection. In this study, we looked at toxicity not only from a single 326 protein and target binding perspective but also in the context of pathways and signaling 327 events. This study is useful to investigate the toxicity targets and pathways interconnected 328 with well-known toxicity pathways.

Examining the broad spectrum of possible pathways enriched for a specific toxicity 330 endpoint enables the investigation of multiple proteins and target binding sites leading 331 to the corresponding toxicity. Our literature-based validation demonstrated that our 332 computational pipeline predicts pathways and proteins associated with AhR toxicity. Even 333 though some experimental studies from the literature support our predictions, further 334 prospective experimental studies are warranted to unequivocally confirm their association 335 with AhR toxicity. These areas are worth improving on in the future by implementing novel 336 machine learning feature selection techniques. In summary, our pipeline implemented 337 within the CANDO platform is useful for hypothesis generation and elucidating toxicity 338 mechanisms at proteomic and pathway scales. The Tox21 compound structures and activity measurements for twelve different qHTS 342 assays were extracted from the Tox21 Data Challenge [11] . The training, evaluation, and 343 test datasets consisted of 11,764, 296, and 647 compounds, respectively. We combined the 344 training and evaluation datasets to form our final training data and used the test data for 345 model evaluation. The twelve qHTS in vitro assays consisted of two categories, seven of 346 which were part of the Nuclear Receptor (NR) and five part of the Stress Response (SR) 347 pathways. The NR assays included the androgen receptor (AR), androgen receptor ligand-348 binding domain (AR-LBD), aryl hydrocarbon receptor (AhR), aromatase, estrogen receptor 349 (ER), estrogen receptor luciferase assay (ER-LBD), and peroxisome proliferator-activated 350 receptor γ (PPAR-γ). The SR assays included the antioxidant response element (ARE), 351 heat shock factor response element (HSE), p53, mitochondrial membrane potential (MMP), 352 and ATPase Family AAA Domain Containing 5 (ATAD5). In each assay, the activity of a 353 compound was assigned a class label, where a label of 1 signified that the compound was 354 active i.e., toxic and a label of 0 signifying that the compound was inactive i.e., not toxic. 355

There were duplicates and inconsistent activity labels for the compounds across the twelve 356 assays (see section 4). 

A human protein library of 19,582 sequences was extracted from UniProt [79] . Of 359 these, 4,966 had at least one solved x-ray diffraction structure in the Protein Data Bank 360 (PDB) [80], including 4,641 with one chain, 298 with two chains, and 27 with three chains, 361 totaling 5,316 total human structures after removing two non-viable ones. These protein 362 structures were chosen by matching their UniProt IDs to all corresponding structures in 363 the PDB, filtering for chains with the most significant sequence coverage to the whole 364 sequence, and then selecting the chain with the best resolution. Proteins were mapped to 365 2,219 pathways in Reactome [81] with an average of 35.1 structures per pathway. The Computational Analysis of Novel Drug Opportunities (CANDO) therapeutic 368 discovery, repurposing, and design platform [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] was used to generate protein inter-369 action signatures for every molecule in its drug/compound library, which served as the 370 feature extraction section in our pipeline. These protein interaction signatures were used as 371 features in our machine learning development. The interaction scores between every com-372 pound in the Tox21 dataset and all structures in the human protein library were computed 373 using a rapid in-house bioanalytical docking (BANDOCK) protocol [43] . First, binding 374 sites were predicted for each protein using COACH [82], a consensus method combining 375 structural and sequence similarity to proteins in the PDB [80], with each prediction having a 376 confidence score (BScore) as well as an associated co-crystallized ligand. Depending on the 377 scoring protocol used, the output interaction score for the compound and protein considers 378 both the BScore and the molecular fingerprint similarity between the compound and the 379 associated ligand (CScore). In this study, the scores were determined by multiplying the 380 BScore by the CScore, which itself is the Sorenson-Dice coefficient [83] that measures the 381 similarity between the ECFP4 fingerprints (computed using RDKit [84]) of the query com-382 pound and binding site ligand. Since the COACH algorithm outputs multiple binding sites 383 (and therefore associated ligands) for each protein, the maximum value of the product of 384 BScore and CScore is the chosen interaction score; this serves as a measure of the likelihood 385 of interaction between a compound and a protein, i.e., a proxy for binding strength. A general overview of the workflow of this study is illustrated in Figure 1 . Our study 388 design consisted of data pre-processing, feature generation, resampling, feature selection, 389 and enrichment analysis. Data pre-processing and feature generation was implemented on 390 both the training and test datasets. Resampling using SMOTE+ENN and feature selection 391 using the random forest algorithm was applied separately to each of the twelve assays in 392 the training dataset. This was followed by model optimization using a repeated stratified 393 three-fold cross-validation using the training data, and model evaluation using the test 394 data. Enrichment analysis was conducted on the ranked list of top 100 protein descriptors 395 selected by the algorithm to analyze the Tox21 toxicity assays at a proteomic and pathway 396 level. These steps are described in detail in the subsequent sections. Compound structures were extracted from the Tox21 Data challenge as SMILES strings. 399 Compound structure standardization and normalization were implemented using the 400 RDKit MolVS library [50] . We applied a fragmentation step as described in [31] , where 401 SMILES with salt moieties, varied resonance structures, and tautomers were removed, and 402 the valid SMILES were canonicalized by normalizing inconsistent chemical groups. To 403 handle the ambiguous compounds with duplicate activities (0 or 1) for the same toxicity 404 assay, we removed compounds with an equal number of active and inactive labels for that 405 particular target. For compounds with an unequal number of active and inactive labels, the 406 most frequent activity label was selected.

Following normalization and merging of the compounds, the resulting SMILES were 408 used to generate a compound-protein interaction score matrix using BANDOCK interaction 409 scoring protocol [43] . This provided the feature descriptor input to the model. The matrix 410 consisted of 7,808 compounds for the training set and 628 compounds for the test set. The 411 generated matrix consisted of 8,385 proteins as feature descriptors. The feature space was 412 filtered for interactions with only solved protein structures, leading to 5316 proteins. The 413 elimination of features reduced the computational requirement and the effect of the curse 414 of dimensionality [85] . The resulting CANDO matrix and the activity measurements of the 415 compounds for each of the twelve different qHTS assays were merged, generating twelve 416 training datasets, one per assay. For each assay, only compounds labeled active or inactive 417 were retained.

To understand the activity measurement distribution for each of the twelve assays, the 419 number of active and inactive compounds for each of the twelve assays was computed, 420 along with the imbalanced ratio, which is the ratio of the majority class (inactive non-toxic 421 compounds) to the minority class (active toxic compounds). As mentioned before, the sparsity in the Tox21 data results in a model that favors the 424 predominant inactive class and misclassifies the minority active class, which is usually the 425 class of interest. We balanced the class distribution for each training set by implement-426 ing the SMOTE+ENN method to address this challenge. SMOTE+ENN combines both 427 oversampling (using SMOTE) and undersampling (using ENN). SMOTE [86] synthesizes 428 samples in the minority class by linear interpolation to increase the number of instances in 429 the minority class. ENN reduces the number of instances in the majority class by removing 430 noisy samples from the majority class, which is inconsistent with its k-nearest neighbors 431 [87]. The SMOTE+ENN algorithm has been shown to deliver promising results when 432 applied to imbalanced datasets with a small number of positive instances, including the 433 Tox21 data [31, 88] . Protocols based on random forest have gained popularity in computational biology 436 research owing to their unique advantages as being non-parametric, interpretable, and 437 highly accurate for cheminformatic modeling [89, 90] . Previous studies using Tox21 have 438 demonstrated the utility of random forest in predicting compound toxicity [19] [20] [21] .

Random forest is an ensemble learning method, combining decision trees as base 440 learners for increased performance [27] . Each tree is trained by different bootstrap samples 441 having the same size as the training set. By selecting a random subset of features at each 442 node in the tree construction, random forest introduces randomization and increased 443 diversity in the forest, reducing the variance of the base learners [91] . The construction of 444 random forest is described by the following steps:

Draw a bootstrap sample: we randomly sample N compounds with replacement from 446 the original dataset. 2) Create maximum decision trees: we construct a decision tree for each bootstrap sample 448 by randomly sampling a subset of features at each node and choosing the best split 449 among those features. 

Given that the Tox21 dataset is high dimensional with a large feature space, traditional 455 methods can lead to model overfitting. However, the random forest algorithm is less 456 susceptible to model overfitting due to the utilization of ensemble strategies and random 457 sampling, and therefore we selected it as our modeling algorithm for this study [30] . The high-dimensional feature space of many tasks in bioinformatics has created a need 460 for sophisticated feature selection techniques [92] . Feature importance is the process of 461 finding parts of the input feature space relevant to a prediction task. The main advantage 462 of using random forest compared to other machine learning algorithms is that it directly 463 performs feature selection during model construction.

A commonly used measure to evaluate the importance of each predictor variable from 465 a random forest classifier is the Gini importance measure, also known as the mean decrease 466 of impurity. As a simple feature importance to rank features, random forest Gini feature 467 importance has gained popularity in bioinformatics applications [92] .

Gini importance is derived from the Gini index [27] , which is a criterion used to 469 determine which feature to split during tree training. It measures the level of impurity of 470 the samples assigned to a node based on a split. Gini index ranges between 0 and 1, where 471 0 means all instances belong to one class, and 1 means that the instances are distributed 472 randomly across the classes. The smaller the Gini index, the purer the node. The Gini index 473 is measured as follows:

where P = (p 1 , p 2 , . . . , p n ), p i is the probability of the class i at a certain node, and n is 475 the number of classes [90] . 476 The Gini importance value of a feature is computed as the sum of the Gini indices 477 weighted by the probability of reaching that node averaged among all trees in the forest. A 478 high Gini importance means that the feature is likely to be informative [93] . Following data pre-processing, SMOTE+ENN was applied to the training data to 481 oversample the minority class and obtain an augmented training set to train the random 482 forest. The random forest was trained with stratified ten-fold cross-validation with three 483 repetitions to optimize the model's hyper-parameters. The hyper-parameters that were 484 optimized included the maximum depth of the tree and the number of trees in the forest. 485 Other model hyper-parameters were set to their respective default values in scikit-learn [94] . 486 Once the random forest model was optimized using the training data, the unseen test data 487 was used to asses the model generalization performance and evaluate the effectiveness of 488 the model. Afterward, the Gini importance was calculated to extract the top 100 weighted 489 feature descriptors.

The model training was applied to each of the twelve datasets, generating an optimized 491 feature selection model with the optimal feature descriptors per assay. The re-sampling 492 technique was applied using the imbalanced-learn package in python [95] and the random 493 forest model was implemented via the scikit-learn python library [94] . Once the model was optimized using the training data, the unseen test data was used 496 to evaluate its performance. We reported both the area under the precision-recall curve 497 (AUPRC) and the area under the receiver-operating characteristic curve (AUCROC) given 498 the class imbalance for the task [96] . We also report the accuracy metric (the proportion of 499 correct predictions relative to the total number of compounds), with the caveat that high 500 accuracy does not translate into a model that correctly predicts the rare inactive class and 501 can therefore be misleading for evaluating model performance [97] .

The decision made by the random forest classifier can be represented in a 2-by-2 503 confusion matrix, given that we have a binary classifier. The confusion matrix has four 504 categories: True positives (TP), the number of active compounds that are correctly labeled. 505 False positives, which is the number of incorrectly labeled inactive chemicals. True nega-506 tives refer to the number of correctly labeled inactive compounds. Lastly, false negatives 507 (FN) correspond to the number of incorrectly labeled inactive compounds. 508 We utilized imbalanced classification metrics derived from the confusion matrix, in-509 cluding recall, precision, F1-score, balanced accuracy, specificity, and Matthews's correlation 510 coefficient (MCC). Recall is a measure of the accuracy of the active minority class. It gives 511 the proportion of actual positives identified correctly by the model, i.e., the number of 512 correctly labeled active compounds out of the actual active compounds. Precision (also 513 called positive predictive value) gives the proportion of positive identifications that were ac-514 tually correct, i.e., the number of correctly labeled active compounds out of the compounds 515 predicted as active. F1 score is the harmonic mean of precision and recall. Specificity is 516 a measure of the accuracy of the inactive majority class. It calculates the proportion of 517 the actual negatives identified correctly by the model, i.e., the number of correctly labeled 518 inactive compounds out of the actual inactive compounds. Balanced accuracy is the average 519 of sensitivity and specificity, and is useful when evaluating a classifier, especially when 520 the classes are imbalanced. MCC is another metric used to assess the quality of binary 521 classification for imbalanced data. It measures the correlation of the true classes with the 522 predicted labels. MCC takes into account all of the four confusion matrix categories. These 523 evaluation metrics were implemented using the scikit-learn package in python [94] . The 524 formulae of the evaluation metrics are as follows: The top 100 most essential proteins for predicting each toxicity endpoint for the com-527 pounds in Tox21 dataset were inputs to an enrichment analysis protocol. The enrichment 528 analysis identifies significantly overrepresented pathways based on their mappings to 529 proteins obtained via Reactome. It utilizes the hypergeometric distribution to determine 530 the probability that a pathway is significantly overrepresented based on the number of 531 proteins in the top feature set associated with the pathway relative to the whole human 532 proteome and the total number of proteins associated with it that pathway. A p-value is 533 computed using the probability mass function with the number of top features associated 534 with the pathway serving as input. The human proteome used in this study includes 19,582 535 proteins from UniProt, of which 4,966 have at least one solved x-ray diffraction structure 536 available in the PDB and are mapped to at least one biological pathway. 

To the best of our knowledge, this is the first computational pipeline that utilizes 539 protein descriptors to extract the important features from the twelve toxicity endpoints in 540 the Tox21 dataset to evaluate compound toxicity. We employed a combination of protocols 541 within the CANDO drug discovery platform, including compound-proteome interaction 542 signature generation, data balancing, feature selection, and enrichment analysis to under-543 stand compound toxicity behavior at the protein pathway level. We expect this computa-544 tional pipeline will provide a novel perspective in evaluating environmental compounds 545 and allow researchers and the pharmaceutical industry to explore the underlying proteomic 546 mechanisms that not only induce toxicity but also potentially assist in developing novel 547 therapeutics to mediate toxicity targets.

Exponential growth of new chemicals and evolution 571 of information relevant to risk control. Annali-Istituto Superiore di Sanità

Techniques: application of systems biology to absorption, 573 distribution, metabolism, excretion and toxicity. Trends in pharmacological sciences

Computational toxicology as implemented by the US EPA: providing high 576 throughput decision support tools for screening and assessing chemical exposure, hazard and 577 risk

579 Quantitative high-throughput screening: a titration-based approach that efficiently identifies 580 biological activities in large chemical libraries

The future of toxicity testing: a focus on in vitro 583 methods using a quantitative high-throughput screening platform. Drug discovery today

Paradigm shift in toxicity testing and modeling. The 586 AAPS journal

Toxicity testing in the 21st century: a vision 589 and a strategy

Toxicity testing in the 21st century: implications for human 592 health risk assessment. Risk analysis: an official publication of the Society for Risk Analysis

Improving the human hazard characterization 595 of chemicals: a Tox21 update

Transforming environmental health protection

The Tox21 data Challenge

Cell-based high-throughput screening for aromatase inhibitors in the 601

Profiling of the Tox21 chemical collection for mitochondrial function to 604 identify compounds that acutely decrease mitochondrial membrane potential. Environmental 605 health perspectives

Profiling of the Tox21 10K compound library for agonists 608 and antagonists of the estrogen receptor alpha signaling pathway

Limited chemical structural diversity found to modulate 611 thyroid hormone receptor in the Tox21 chemical library

Rossoshek, 614 A.; Simeonov, A. Tox21Challenge to build predictive models of nuclear receptor and stress 615 response pathways as mediated by exposure to environmental chemicals and drugs

Prediction of compounds activity in nuclear receptor signaling and stress pathway 618 assays using machine learning algorithms and low-dimensional molecular descriptors. Frontiers 619 in Environmental Science

Integrated model of chemical perturbations of a 622 biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor

Rigorous selection of random forest models for identifying compounds that activate 625 toxicity-related pathways

Identifying biological pathway interrupting toxins using multi-tree ensembles. Fron-627 tiers in Environmental Science

Predictive toxicology: modeling chemical 629 induced toxicological response combining circular fingerprints with random forest and support 630 vector machine

DeepTox: toxicity prediction using deep 632 learning

Feature Extraction: Foundations and Applications; 634 Studies in Fuzziness and Soft Computing

A survey on feature selection methods

Application of random forest algorithm on feature subset selection 638 and classification and regression

A review of feature selection methods in medical applications. 641 Computers in biology and medicine

Random Forests. Machine learning

Selecting critical features for data classification 644 based on machine learning methods

Gene selection and classification of microarray data using 646 random forest

Identifying feature relevance using a random forest. International Statistical 648 and Optimization Perspectives Workshop" Subspace, Latent Structure and Feature Selection

Zhang, 651 C.; Gong, P. Structure-activity relationship-based chemical classification of highly imbalanced 652 Tox21 datasets

Prediction is a balancing act: importance of sam-654 pling methods to balance sensitivity and specificity of predictive models based on imbalanced 655 chemical data sets

Predictive modeling of biological responses in the rat liver

Tox21 bioactivity: Benefits from high-throughput toxicokinetics

LightGBM: An effective and scalable algorithm 661 for prediction of chemical toxicity-application to the Tox21 and mutagenicity data sets

Imbalanced Toxicity Prediction Using Multi-Task Learning and Over-Sampling

Prediction of HIV-1 protease inhibitor resistance using a 666 protein-inhibitor flexible docking approach

New paradigms for drug discovery: Computational multitarget 668 screening

CANDO 670 and the infinite drug discovery frontier. Drug discovery today

Multiscale modelling of relationships between protein 672 classes and drug behavior across all diseases using the CANDO platform. Mini reviews in 673 medicinal chemistry

Exploring polypharmacology in drug discovery and repurposing 675 using the CANDO platform

Combating Ebola with repurposed therapeutics 677 using the CANDO platform

Identifying protein features responsible for improved drug 679 repurposing accuracies using the CANDO platform: Implications for drug design

Exploration of interaction scoring criteria in 682 the CANDO platform

Shotgun Drug Repurposing. ACS omega

Computational chemoproteomics to understand 686 the role of selected psychoactives in treating mental health disorders

Shotgun drug repurposing 688 biotechnology to tackle epidemics and pandemics. Drug Discovery Today

Open Source Software for

Predictive Bioanalytics of Large Scale Drug-Protein-Disease Data

Multiscale virtual screening optimization for shotgun drug 693 repurposing using the CANDO platform

Eval-695 uating the performance of drug-repurposing technologies. Drug Discovery Today 2021

RDKit MolVS python package

The AH-receptor: genetics, structure and function

Functional role of AhR in the expression of toxic effects by TCDD. 702

Aryl hydrocarbon receptor-704 deficient mice generate normal immune responses to model antigens and are resistant to 705 TCDD-induced immune suppression

Carcinogenicity of TCDD: experimental, mechanistic, and 707 epidemiologic evidence. Annual review of pharmacology and toxicology

Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorige-709 nesis

The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact 711 and tumor growth

Aryl hydrocarbon receptor control of adaptive immunity. Pharmaco-713 logical reviews

Environmental toxicants and the developing immune 715 system: a missing link in the global battle against infectious disease?

Subchronic exposure to TCDD, PeCDF, PCB126, and 718 PCB153: effect on hepatic gene expression

Aryl hydrocarbon 720 receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries

The significance of the nongenomic pathway in mediating inflammatory sig-723 naling of the dioxin-activated Ah receptor to cause toxic effects

726 BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in 727 human breast cancer cells

TCDD affects DNA double strand-break repair

Inhibition of E2-induced expression 731 of BRCA1 by persistent organochlorines

El-Deiry, W.S. BRCA1 effects on the cell cycle and the DNA damage response are linked to 734 altered gene expression

BRCA1 required for 736 transcription-coupled repair of oxidative DNA damage

BRCA1 gene in breast cancer

Inhibition of 740 BRCA-1 expression by benzo [a] pyrene and its diol epoxide. Molecular Carcinogenesis: Published 741 in cooperation with the University of Texas MD Anderson Cancer Center

Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. 747 Archives of biochemistry and biophysics

Benzo [a] pyrene inhibits osteoclastogenesis 749 by affecting RANKL-induced activation of NF-κB

Signaling to NF-κB

Role of osteopontin 752 in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 753 1β through the NF-κB and MAPK pathways in rheumatoid arthritis

Role of RANKL in physiological and patholog-756 ical bone resorption and therapeutics targeting the RANKL-RANK signaling system

Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of 760 gene-environment interaction in autoimmune arthritis

763 Göttlicher, M. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated 764 p38-MAPK-dependent pathway

Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating 767 enzyme complex and a unique polyubiquitin chain

Inhibition of TRAF6-Ubc13 interaction in NFkB inflammatory pathway 769 by analyzing the hotspot amino acid residues and protein-protein interactions using molecular 770 docking simulations

UniProt: the universal protein knowledgebase in 2021

Protein Data Bank: the single global archive for 3D macromolecular structure data

The reactome pathway knowledgebase

Protein-ligand binding site recognition using complementary 780 binding-specific substructure comparison and sequence profile alignment

A method of establishing groups of equal amplitude in plant sociology based 783 on similarity of species content and its application to analyses of the vegetation on Danish 784 commons

Dynamic programming

SMOTE: synthetic minority over-788 sampling technique

A KNN undersampling approach for data 790 balancing

A Study of The Behavior of Several Methods for 792 Balancing Machine Learning Training Data

Random forest: a 794 classification and regression tool for compound classification and QSAR modeling

Random forest for bioinformatics

An experimental comparison of three methods for constructing ensembles of 799 decision trees: Bagging, boosting, and randomization

A review of feature selection techniques in bioinformatics. 801 bioinformatics

The revival of the Gini importance?

Scikit-learn: Machine learning in python

Imbalanced-Learn: A Python Toolbox to 808 Tackle the Curse of Imbalanced Datasets in Machine Learning

The relationship between Precision-Recall and ROC curves

Using AUC and accuracy in evaluating learning algorithms